Trials / Conditions / Advanced Non-small Cell Lung Cancer (NSCLC)

Advanced Non-small Cell Lung Cancer (NSCLC)

8 registered clinical trials studyying Advanced Non-small Cell Lung Cancer (NSCLC) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers NCT07259226	UNICANCER	Phase 2
Not Yet Recruiting	Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A R NCT07190027	First Affiliated Hospital of Wenzhou Medical University	Phase 1 / Phase 2
Enrolling By Invitation	Complications Associated With Lymphadenectomy (LAD) in Surgical Treatment of Non-small Cell Lung Cancer (NSCLC NCT07401498	Regional Clinical Oncology Dispensary	N/A
Recruiting	Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors NCT06773507	Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.	Phase 1
Recruiting	Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung NCT06728852	Li-kun Chen	Phase 2
Completed	ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer NCT02175017	Ono Pharmaceutical Co., Ltd.	Phase 2
Terminated	An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCL NCT01646125	Novartis Pharmaceuticals	Phase 2
Completed	Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lun NCT01101334	Daiichi Sankyo	Phase 2